Cancer Care Ontario | Action Cancer Ontario

5 Results

Guidelines and Advice

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Status: In-Review
ID: GL END 7-3
Version: 4

Dec 1969

Guidelines and Advice

Status: Current

Dec 1969

Guidelines and Advice

Status: Current
ID: GL 3-20
Version: N/A

Dec 1969

Guidelines and Advice

Status: Current
ID: GL 2-30a
Version: N/A

Mar 2020

Guidelines and Advice

Status: Current
ID: GL END 5-13
Version: N/A

Dec 1969